Qiu Qin Lou

Director/Board Member en HaploX Investment Holding Ltd. .

44 años

Consumer Services

Commercial Services

Perfil

Qiu Qin Lou is an Independent Non-Executive Director at HaploX Investment Holding Ltd.
Currently, Dr. Lou has only one job.
Dr. Lou completed an undergraduate degree from Zhongnan University of Economics & Law in 2001.
Dr. Lou also completed a graduate degree and a doctorate from China University of Political Science & Law in 2021.

Cargos activos de Qiu Qin Lou

Empresas	Cargo	Inicio
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Director/Board Member	-

Todos los cargos activos de Qiu Qin Lou

Formación de Qiu Qin Lou.

Zhongnan University of Economics & Law	Undergraduate Degree
China University of Political Science & Law	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Qiu Qin Lou.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Commercial Services